Market Research NewsNews

Point of Care Molecular Diagnostics Market Analytical Overview, Growth Factors, Demand and Trends Forecast Report till 2026

Global Point of Care Molecular Diagnostics Market

Point of care molecular diagnostic tests are used in the diagnosis of diseases and their control, management and surveillance. Point of care molecular diagnostic tests can improve the efficiency, accessibility in terms of diagnosis and also improves the healthcare infrastructure.  Point of care molecular diagnostic tests are used in the diagnosis of various infectious diseases in day to day life which provide fast, accurate and rapid diagnostic result and the treatment to the patients.

Avail Discount at (Special Offer: This report is available up to 10% discount for a limited time only):

Request for Free sample of this research report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-molecular-diagnostics-market

The Point of Care Molecular Diagnostics Market report has been prepared by taking into account several aspects of marketing research and analysis which includes market size estimations, market dynamics, company & market best practices, entry level marketing strategies, positioning and segmentations, competitive landscaping, opportunity analysis, economic forecasting, industry-specific technology solutions, roadmap analysis, targeting key buying criteria, and in-depth benchmarking of vendor offerings.

Global Point of Care Molecular Diagnostics Market

According to Data Bridge Market Research new Market report, global point of care molecular diagnostics market accounted to USD 722.4million in 2018 growing at a CAGR of 15.1% during the forecast period of 2019 to 2026.

Key Market Competitors:

Few of the major competitors currently working in the point of care molecular diagnostics market are Agilent Technologies Inc., Abbott, F. Hoffmann-La Roche Ltd., Illumina Inc., Hologic Inc., QIAGEN, Myriad Genetics, Cepheid, Genomic Health, GenePOC Inc., DxNA LLC., Binx Health Inc., Spartan Bioscience Inc., Biocartis, Beckman Coulter Inc., Johnson & Johnson Services Inc., Medtronic, Siemens Healthcare GmbH, Grifols S.A., Abaxis, Bayer AG, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher, OraSure Technologies Inc., BD, Sysmex Corporation, Quidel Corporation, and Meridian Bioscience Inc..

Competitive Analysis: 

The Global Point of Care Molecular Diagnostics Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Point of Care Molecular Diagnostics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Drivers:

  • Increasing cases of infectious diseases causing the health professionals to determine the infections and its causes accurately in a timely manner, thereby increasing the demand for Point of Care Molecular Diagnostics Market.
  • Increased demand for regulatory approved molecular tests driving the market

Table of Contents:

  1. Introduction
  2. Research Methodology
  3. Executive Summary
  4. Market Insights
  5. Point of Care Diagnostics Market, by Product
  6. Point of Care Diagnostics Market, by Platform
  7. Point of Care Diagnostics Market, by Mode
  8. Point of Care Diagnostics Market, by End User
  9. Point of Care Diagnostics Market, by Geography
  10. Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)

To Understand Complete Table Of Content, Tables And Figures @ https://databridgemarketresearch.com/toc/?dbmr=global-point-of-care-molecular-diagnostics-market

Segmentation: 

Global point of care molecular diagnostics market is segmented on the basis of product, application, technology, end user and geography.

By Product (Assays & Kits, Instruments/Analyzers, Services & Software), Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infection, Oncology, Hepatitis, Others), Technology (Polymerase Chain Reaction, In-Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others), End-User (Physician Offices, Hospitals, Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close